SamaCare Releases Benchmarks for Medical Benefit Prior Authorization Performance
SamaCare announced in a press release the launch of its Medical Benefit Prior Authorization Benchmarks, a dataset that offers visibility into approval rates and time to therapy for specialty medications. The dataset is based on real prior authorization activity from tens of thousands of specialty practices using SamaCare's platform.
The benchmarks provide quarterly insights into two key metrics that affect patient access to therapy: Net Approval Rate and Mean Time to Resolution. These measures track how payer policies are applied in practice and how quickly patients move from authorization to treatment.
In addition to the public benchmarks, SamaCare is offering life sciences organizations the option to generate custom Access Snapshots for individual therapies. These reports provide deeper insights into approval performance, time to therapy, and the main factors influencing access barriers.
The release arrives amid growing attention to prior authorization reform and transparency in healthcare administration.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more